Updated:
Human Longevity
The most comprehensive executive health assessment — full-body MRI, whole genome sequencing, 120+ biomarkers & AI analysis in one visit. Starting at $8,000.
Human Longevity
The most comprehensive executive health assessment — full-body MRI, whole genome sequencing, 120+ biomarkers & AI analysis in one visit. Starting at $8,000.
General information
Firm type
other
Year founded
2013
Location
Region
North America
Country
United States
City
San Diego
Corporate office
San Diego, CA, United States
Additional offices
San Francisco, CA, United States
Principals
Dr. J. Craig Venter
Co-Founder
Tina Ziainia, MD, FACOG
President & Medical Director — San Diego
Keon Pearson, MD, MBA
Medical Director — San Francisco & Director, Executive Health
David Karow, MD, PhD
Chief Clinical Advisor
Sector focus
Frequently asked questions
Who runs the clinical team at Human Longevity?
The clinical team is led by Dr. Tina Ziainia, President and Medical Director of the San Diego clinic, and Dr. Keon Pearson, Medical Director of the San Francisco clinic and Director of Executive Health. Dr. David Karow serves as Chief Clinical Advisor. All clinicians are board-certified and trained at institutions including Stanford, Harvard, UCSF, and the Cleveland Clinic (per firm website).
What does the Human Longevity assessment include?
The standard program includes whole genome sequencing, whole body MRI with NeuroQuant, brain MRI, echocardiogram, EKG, CT calcium score, DEXA scan, and 120+ blood biomarkers. The premium tier adds a continuous glucose monitor, Zio Patch cardiac monitoring, GRAIL multi-cancer blood test, cardiac MRI, low-dose CT of the lung, and quarterly physician follow-ups (per firm website, 2026).
Is Human Longevity a family office or an investment firm?
No. Human Longevity is a private healthcare company that sells executive health assessments and longevity memberships. It is not structured as a family office, does not manage third-party capital, and does not make investments. The firm generates revenue from client fees (per firm website).
How is Dr. J. Craig Venter involved with the firm today?
Dr. J. Craig Venter is listed as co-founder on the firm's website. His role in day-to-day operations is not disclosed, but his scientific legacy — sequencing the first human genome in 2000 — directly underlies the firm's approach. The firm continues to reference his work in its marketing and research publications (per firm website).
Does Human Longevity accept insurance or only private pay?
The firm's website does not mention insurance acceptance. The standard assessment starts at $8,000 and appears to be entirely private-pay. The firm states 'We respect your privacy. No spam, no sharing your data' on its contact page (per firm website).
What is the scientific evidence behind Human Longevity's protocols?
The firm reports over 20 peer-reviewed publications in journals including Nature Genetics, PNAS, and Genome Medicine. A 2020 PNAS paper by Venter et al. demonstrated its approach to phenotypic aging analysis. The firm is ranked among the top 50 biomedical companies globally by Nature Index (per firm website).
How does Human Longevity use artificial intelligence?
The firm offers a Longevity AI app that translates complex diagnostic data into personalized recommendations. Geoffrey Hinton, Nobel laureate and pioneer of deep learning, sits on the Scientific Advisory Board. The firm uses AI to analyze whole genome sequences, MRI images, and biomarker data for early disease detection (per firm website).
Profile maintained by Altss using OSINT (open-source intelligence), regulatory filings, licensed data partners, and verified direct submissions. Read the methodology. Last updated: . Continuous refresh with full update cycles at least every 30 days.
Need institutional-grade insight on investors?
Altss delivers:
Prefer a guided tour?
We’ll walk you through: